Low fermentable oligo-, di-, monosaccharides, and polyols (FODMAP) diet as a treatment option in paediatric patients with functional gastrointestinal disorders
Authors:
Šácha Ondřej 1; Zárubová Kristýna 2
Authors‘ workplace:
Dětská klinika, Fakulta zdravotnických studií, Univerzita Jana Evangelisty Purkyně a Masarykova nemocnice Ústí nad Labem
1; Pediatrická klinika, 2. lékařská fakulta, Univerzita Karlova a FN Motol, Praha
2
Published in:
Čes-slov Pediat 2024; 79 (4): 195-199.
Category:
Pediatric Protocols in Praxis
doi:
https://doi.org/10.55095/CSPediatrie2024/043
Overview
Dietary measures based on the exclusion of fermentable oligo-, di-, monosaccharides, and polyols (low-FODMAP diet) are increasingly being used in treating certain gastrointestinal diseases in children. The following text summarizes essential recommendations for using the low-FODMAP diet, based on the position paper of the European Society for Pediatric Gastroenterology, Hepatology and Nutrition (ESPGHAN) issued in September 2022. It includes recommendations on initiation, duration, gradual cessation, monitoring, professional guidance, safety, and risks. Currently, there is limited evidence supporting the use of this diet in children, primarily only for some pediatric patients suffering from functional gastrointestinal disorders (FGID), specifically children with functional abdominal pain (FAP), such as irritable bowel syndrome (IBS) according to the Rome IV criteria from 2016. There is no evidence for the use of the low-FODMAP diet in other gastrointestinal diseases in children, such as constipation, inflammatory bowel disease, celiac disease, non-celiac gluten sensitivity, or small intestinal bacterial overgrowth.
Keywords:
Diet – Irritable bowel syndrome – children – FODMAP – functional abdominal pain
Sources
1. Iacovou M, Tan V, Muir JG, Gibson PR. The low FODMAP diet and its application in East and Southeast Asia. J Neurogastroenterol Motil 2015; 21(4): 459–70.
2. Tuck CJ, Reed DE, Muir JG, Vanner SJ. Implementation of the low FODMAP diet in functional gastrointestinal symptoms: A real-world experience. Neurogastroenterol Motil 2020; 32(1): e13730.
3. Chumpitazi BP, Cope JL, Hollister EB, et al. Randomised clinical trial: gut microbiome biomarkers are associated with clinical response to a low FODMAP diet in children with the irritable bowel syndrome. Aliment Pharmacol Ther 2015; 42: 418–27.
4. Dogan G, Yavuz S, Aslantas H, et al. Is low FODMAP diet effective in children with irritable bowel syndrome? North Clin Istanb 2020; 7(5): 433–437.
5. Boradyn KM, Jarocka-Cyrta E, Przybylowicz KE, et al. Parental opinion about the low diet in dietary treatment of children with functional abdominal pain. Int J Environ Res Public Health 2020; 17: 5554.
6. Baranguan Castro ML, Ros Arnal I, et al. [Implementation of a low FODMAP diet for functional abdominal pain]. An Pediatr (Barc) 2019; 90: 180–6.
7. Skodje GI, Sarna VK, Minelle IH, et al. Fructan, rather than gluten, induces symptoms in patients with self-reported non-celiac gluten sensitivity. Gastroenterology 2018; 154: 529–539.e2.
8. Thomassen RA, Luque V, Assa A, et al. An ESPGHAN position paper on the use of low-FODMAP diet in pediatric gastroenterology. J Pediatr Gastroenterol Nutr 2022; 75(3): 356–368.
9. Pensabene L, Salvatore S, Turco R, et al. Low FODMAPs diet for functional abdominal pain disorders in children: critical review of current knowledge. J Pediatr (Rio J) 2019; 95: 642–56.
10. Whelan K, Martin LD, Staudacher HM, et al. The low FODMAP diet in the management of irritable bowel syndrome: an evidence-based review of FODMAP restriction, reintroduction and personalisation inclinical practice. J Hum Nutr Diet 2018; 31: 239–55.
11. Nogay NH, Walton J, Roberts KM, et al. The effect of the low FODMAP diet on gastrointestinal symptoms, behavioral problems and nutrient intake in children with autism spectrum disorder: a randomized controlled pilot trial. J Autism Dev Disord 2021; 51(8): 2800–2811.
12. Eswaran S, Dolan RD, Ball SC, et al. The impact of a 4-week low-FODMAP and mNICE diet on nutrient intake in a sample of US adults with irritable bowel syndrome with diarrhea. J Acad Nutr Diet 2020; 120(4): 641–649.
Labels
Neonatology Paediatrics General practitioner for children and adolescentsArticle was published in
Czech-Slovak Pediatrics
2024 Issue 4
- Diagnosis of Cow Milk Protein Allergy − Current Methods and Their Diagnostic Value
- Subcutaneous vs. Intravenous Immunoglobulins in Patients with CLL
- Inosine pranobex in the treatment of influenza and other respiratory infections of viral etiology
- Inosine Pranobex in the Treatment of Cervical HPV Infections
Most read in this issue
- Current procedures in diagnosis, treatment and prevention of cow's milk protein allergy (CMPA)
- Malabsorption syndromes
- Clinical presentation and management of childhood lipodystrophic syndromes
- Role dietních intervencí v prevenci a léčbě diabetu 1. typu